Molecular Cancer

Papers
(The H4-Index of Molecular Cancer is 93. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Genome-wide CRISPR screening identifies tyrosylprotein sulfotransferase-2 as a target for augmenting anti-PD1 efficacy1359
Correction: m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC857
Chaperone-mediated autophagy modulates Snail protein stability: implications for breast cancer metastasis808
Correction to: The function and mechanisms of action of circular RNAs in Urologic Cancer798
Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers582
Immunotherapies in rare cancers541
The miR-23a/27a/24 − 2 cluster drives immune evasion and resistance to PD-1/PD-L1 blockade in non-small cell lung cancer534
The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC496
Engineered multifunctional nanoparticles for enhanced radiation therapy: three-in-one approach for cancer treatment475
The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments473
circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis472
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway465
LMTK3 regulation of EV biogenesis and cargo sorting promotes tumour growth by reducing monocyte infiltration and driving pro-tumourigenic macrophage polarisation in breast cancer404
Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers399
Using single-cell sequencing technology to detect circulating tumor cells in solid tumors353
E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer313
ERK mediates interferon gamma-induced melanoma cell death274
Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma272
The epigenetic regulatory mechanism of PIWI/piRNAs in human cancers269
Integrative gene network and functional analyses identify a prognostically relevant key regulator of metastasis in Ewing sarcoma259
JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression255
The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis253
TGF-β signaling promotes cervical cancer metastasis via CDR1as253
CRISPR based therapeutics: a new paradigm in cancer precision medicine248
EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3247
Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery223
LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling214
Exosomal circSIPA1L3-mediated intercellular communication contributes to glucose metabolic reprogramming and progression of triple negative breast cancer212
Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells199
The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research193
Correction: YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment192
Effects of RNA methylation on Tumor angiogenesis and cancer progression186
Myofibroblast-derived extracellular vesicles facilitate cancer stemness of hepatocellular carcinoma via transferring ITGA5 to tumor cells183
Correction to: The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs181
Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis180
Biofilm formation by the host microbiota: a protective shield against immunity and its implication in cancer167
PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN166
Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-κB p65 nuclear translocation161
KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis161
Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection160
A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state157
LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling156
Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer152
NK cells are never alone: crosstalk and communication in tumour microenvironments149
Insights into N6-methyladenosine and programmed cell death in cancer146
Gold nanoparticles and gold nanorods in the landscape of cancer therapy143
Tumor cell-intrinsic MELK enhanced CCL2-dependent immunosuppression to exacerbate hepatocarcinogenesis and confer resistance of HCC to radiotherapy143
Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer140
Emerging roles of tRNA-derived fragments in cancer138
Nanotechnology-leveraged CRISPR/Cas systems: icebreaking in trace cancer-related nucleic acids biosensing136
Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes136
Bidirectional role of neutrophils in tumor development135
Nuclear receptors as novel regulators that modulate cancer radiosensitivity and normal tissue radiotoxicity135
Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments133
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer132
Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies130
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy130
lncRNAs: the unexpected link between protein synthesis and cancer adaptation129
Correction: Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1128
Correction: CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling125
CircAKT3 promotes prostate cancer proliferation and metastasis by enhancing the binding of RPS27A and RPL11125
Retraction Note: Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis122
Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment122
Dissecting small cell carcinoma of the esophagus ecosystem by single-cell transcriptomic analysis122
A positive feedback loop between PFKP and c-Myc drives head and neck squamous cell carcinoma progression120
An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks119
Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma116
Crosstalk between autophagy and microbiota in cancer progression114
Identification of multidrug chemoresistant genes in head and neck squamous cell carcinoma cells113
Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance111
Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumors111
Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression111
The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer110
Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin108
Loss of TACC2 impairs chemokine CCL3 and CCL4 expression and reduces response to anti-PD-1 therapy in soft tissue sarcoma106
DLL3-guided therapies in small-cell lung cancer: from antibody-drug conjugate to precision immunotherapy and radioimmunotherapy105
Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing105
EMT/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin?105
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer102
Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring102
Circular RNA circCLASP2 promotes nasopharyngeal carcinoma progression through binding to DHX9 to enhance PCMT1 translation101
Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition101
Molecular mechanisms of tumor resistance to radiotherapy99
Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer99
m6A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma97
Correction to: Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma96
Cancer neuroscience in head and neck: interactions, modulation, and therapeutic strategies96
N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer96
Size matters: integrating tumour volume and immune activation signatures predicts immunotherapy response96
Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer96
Activation-induced cytidine deaminase causes recurrent splicing mutations in diffuse large B-cell lymphoma95
Inhibition of 6-phosphogluconate dehydrogenase suppresses esophageal squamous cell carcinoma growth and enhances the anti-tumor effects of metformin via the AMPK/mTOR pathway93
Correction: Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy93
0.05431079864502